17 Apr, 2025 - A-TANGO

A-TANGO related activities at EASL Congress 2025

A-TANGO strives to increase the survival rate with G-TAK – a novel combinatorial therapy, and to decrease the burden on the national healthcare systems, which is caused by a large percentage of patients who never recover fully and require long-term care.

Wednesday 7 May

When	Where	What
14:00-15:00	D202 (Level 2 of the Elicium Building)	A-TANGO Patient & Layman Event Speakers: Marko Korenjak (ELPA), Rajiv Jalan (UCL), and Cornelius Engelmann (Charité) Organiser: European Liver Patients‘ Association (ELPA)
17:45-17:50	Arnold Room	Opening remarks - addressing disparities in healthcare in the Netherlands Speaker: Minneke Coenraad (LUMC) Part of: Patient & Advocate Forum: Culturally Competent Care: providing for patients in marginalized communities
08:30-17:00	Poster Area (also available as ePoster)	POSTER ID WED-437: suPAR levels independently discriminate patients with at-risk MASLD Presenter: Julian Pohl (Charité)

Thursday 8 May

When	Where	What
15:35-15:45	Erlinger Room	Managing financial conflicts of interest Speaker: Rajiv Jalan (UCL) Part of: YI seminar: Science to start-up – Embracing entrepreneurship in hepatology
17:00-19:00	D202 (Level 2 of the Elicium Building)	A-TANGO Investigator & Industry Meeting Speakers: Rajiv Jalan (UCL), Cornelius Engelmann (Charité), and A-TANGO partners Organiser: The event includes catering and is sponsored by A-TANGO partner Yaqrit Ltd.
08:30-17:00	Poster Area (also available as ePoster)	POSTER ID TOP-203 Recombinant insulin-like growth factor-1: a novel therapy for patients with cirrhosis and ACLF Presenter: Wenting Tan (UCL)

Friday 9 May

When	Where	What
08:30-17:00	Poster Area (also available as ePoster)	POSTER ID TOP-217-YI Pathophysiological basis of acute on chronic liver failure (ACLF) triggered by alcohol-related hepatitis or infection using circulating biomarkers of inflammation, circulatory dysfunction and albumin modifications Presenter: Julian Pohl (Charité)
08:30-17:00	Poster Area (also available as ePoster)	POSTER ID FRI-192 Loss of paraspinal skeletal muscle tissue is independently associated with increased 90-, but not 28-day mortality in patients with acute-on-chronic liver failure Presenter: Julian Pohl (Charité)
08:30-17:00	Poster Area (also available as ePoster)	POSTER ID FRI-156 Coordinated liver tissue regeneration becomes ineffective with increasing injury in patients with acute indeterminate liver failure Presenter: Richard Sittner (Charité)

Saturday 10 May

When	Where	What
08:30-16:00	Poster Area (also available as ePoster)	POSTER ID SAT-210 Development and validation of the modified hepatic encephalopathy staging tool (mHEST) for grading of hepatic encephalopathy for accurate assessment and regulated clinical trials Presenter: Rajiv Jalan (UCL)
08:30-16:00	Poster Area (also available as ePoster)	POSTER ID SAT-209 Randomized, open-label, phase 2a comparator study to assess the pharmacodynamics, safety and pharmacokinetics of oral administration of mnk6106 (l-ornithine phenylacetate) vs. rifaximin in subjects with hepatic cirrhosis and a previous history of hepatic encephalopathy Presenter: Rajiv Jalan (UCL)
09:45-10:15	Cirrhosis & Complications Track Hub	A-TANGO Networking Session Speakers: Rajiv Jalan (UCL) and Young Investigators (YI) of A-TANGO
10:35-10:50	Eddleston Room	Table 2: Delphi Method Speaker: Frank Tacke (Charité) Part of: YI workshop: How to prepare a Clinical Practice Guideline in Hepatology
14:45-14:55	Benhamou Room	Viral hepatitis Speaker: Thomas Berg (ULEI) Part of: General Session “Congress Highlights”